Literature DB >> 16787874

A novel mutation W252X in the WAS gene in a Korean patient with Wiskott-Aldrich syndrome.

Hee-Jin Kim1, Eun-Hyung Yoo, Chang-Seok Ki, Geon-Hee Yoo, Hong-Hoe Koo, Jong-Won Kim, Sun-Hee Kim.   

Abstract

Wiskott-Aldrich syndrome (WAS) is a primary immunodeficiency disorder characterized by recurrent infection, eczema, and microthrombocytopenia. WAS is inherited in an X-linked recessive pattern, and various mutations in the WAS gene on the X chromosome are the genetic basis of WAS. A 7-month-old Korean boy presented with recurrent bloody diarrhea, eczema, and persistent thrombocytopenia with small platelets. Direct sequence analysis of the entire coding region of the WAS gene showed a novel nonsense mutation with a G-to-A substitution at the nucleotide position 756 on exon 8, leading to a premature termination at codon 252 (c.756G>A; p.W252X). Family study revealed that neither of the parents had the mutation, indicating the de novo occurrence of the mutation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787874     DOI: 10.1532/IJH97.A30513

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  8 in total

Review 1.  Nonsense-mediated mRNA decay in health and disease.

Authors:  P A Frischmeyer; H C Dietz
Journal:  Hum Mol Genet       Date:  1999       Impact factor: 6.150

2.  Mutational analysis of the WASP gene in 2 Korean families with Wiskott-Aldrich syndrome.

Authors:  Eun-Kyeong Jo; Takeshi Futatani; Hirokazu Kanegane; Takeo Kubota; Young-Ho Lee; Jin-A Jung; Chang-Hwa Song; Jeong-Kyu Park; Shigeaki Nonoyama; Toshio Miyawaki
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

3.  Unique and recurrent WAS gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia.

Authors:  L J Thompson; M R Lalloz; D M Layton
Journal:  Blood Cells Mol Dis       Date:  1999 Jun-Aug       Impact factor: 3.039

4.  Isolation of a novel gene mutated in Wiskott-Aldrich syndrome.

Authors:  J M Derry; H D Ochs; U Francke
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

5.  Clinical course of patients with WASP gene mutations.

Authors:  Kohsuke Imai; Tomohiro Morio; Yi Zhu; Yinzhu Jin; Sukeyuki Itoh; Michiko Kajiwara; Jun-Ichi Yata; Shuki Mizutani; Hans D Ochs; Shigeaki Nonoyama
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

6.  Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation.

Authors:  Yinzhu Jin; Cinzia Mazza; Jacinda R Christie; Silvia Giliani; Maurilia Fiorini; Patrizia Mella; Francesca Gandellini; Donn M Stewart; Qili Zhu; David L Nelson; Luigi D Notarangelo; Hans D Ochs
Journal:  Blood       Date:  2004-07-29       Impact factor: 22.113

7.  Two novel mutations of Wiskott-Aldrich syndrome: the molecular prediction of interaction between the mutated WASP L101P with WASP-interacting protein by molecular modeling.

Authors:  Moon Kyu Kim; Eun Sook Kim; Dong Soo Kim; In-Hong Choi; Taesung Moon; Chang No Yoon; Jeon-Soo Shin
Journal:  Biochim Biophys Acta       Date:  2004-10-14

Review 8.  Mechanisms of WASp-mediated hematologic and immunologic disease.

Authors:  Siobhan Burns; Giles O Cory; William Vainchenker; Adrian J Thrasher
Journal:  Blood       Date:  2004-08-12       Impact factor: 22.113

  8 in total
  3 in total

1.  A case of familial X-linked thrombocytopenia with a novel WAS gene mutation.

Authors:  Eu Kyoung Lee; Yeun-Joo Eem; Nack-Gyun Chung; Myung Shin Kim; Dae Chul Jeong
Journal:  Korean J Pediatr       Date:  2013-06-21

2.  Genetic classification and confirmation of inherited platelet disorders: current status in Korea.

Authors:  Ye Jee Shim
Journal:  Clin Exp Pediatr       Date:  2020-02-06

3.  A familial case of Wiskott-Aldrich Syndrome with a hotspot mutation in exon 2 of the WAS Gene.

Authors:  Sook Kyung Park; Chun Soo Kim; Dae Kyu Song; Joo Young Kim; In Jang Choi; Dae Kwang Kim
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.